The European Commission (EC) has proposed a series of targeted actions to boost biotechnology and biomanufacturing in Europe.
These proposed actions were set out in a communication issued by the EC last week.
They include leveraging research and boosting innovation, stimulating market demand, streamlining regulatory pathways, fostering public and private investments and strengthening biotech-related skills.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze